<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="antioxidants-09-00636-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">antioxidants-09-00636-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>This represents a list of functional hemoproteins and the clinical scenarios caused by dysfunction of these hemoproteins. Key: AKI = acute kidney injury, ARF = acute renal failure, CHF = congestive heart failure, AOCI = anemia of chronic inflammation.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Consequences of Hemoprotein Malfunction/Deficiency</th>
   </tr>
   <tr>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemoprotein</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deficiency Consequence</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical Manifestation</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Main Organs Affected</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Catalase</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↑ ROS formation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue damage</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High [ACE-2R] organs</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytochrome of the ETC</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ Aerobic respiration
     <break/>↑ Apoptosis
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue damage</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High [ACE-2R] organs</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO synthetase </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ vessel hemostasis
     <break/>↓ smooth M. relaxation
     <break/>↑ cardiac contractility
     <break/>↓ regulation of renal hemodynamics, sodium regulation, and tubuloglomerular feedback
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prothrombotic state
     <break/>Vasoconstriction
     <break/>CHF/tachycardia
     <break/>AKI/ARF
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High [ACE-2R] organs</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myoglobin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↑ Rhabdomyolysis </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhabdomyolysis
     <break/>Acute kidney injury
     <break/>Electrolyte derangement
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skeletal muscle</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemoglobin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↓ O
     <sub>2</sub> and CO
     <sub>2</sub> affinity
     <break/>↓ Production
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged and increasing O
     <sub>2</sub> requirements
     <break/>Anemia (AOCI)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RBCs</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All cells with porphyrin
     <break/>in membrane
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No deficiency. Allows COVID-19 to bind with high affinity leading to infection </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Progressive tissue damage, especially as virus continues to replicate within the cell</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low [ACE-2R]
     <break/>organs
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
